Baygam Solution For Injection 15pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Baygam: Solution for injection (15%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

IMMUNE GLOBULIN (im MUNE GLOB yoo lin) helps to prevent or reduce the severity of certain infections in patients who are at risk. This medicine is collected from the pooled blood of many donors. It is used to treat immune system problems, thrombocytopenia, and Kawasaki syndrome.

In-Depth Information

BayGam 15% Solution for Injection

NDC: 000260635
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hepatitis A Prophylaxis, Measles Prophylaxis, Rubella Prophylaxis, Immunoglobulin Deficiency, Varicella (chickenpox) Infection Prophylaxis

BayGam 15% Solution for Injection

Reported Side Effects for BayGam 15% Solution for Injection

Flu Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Bleeding Incidence:
<29.0%*
Severity: MODERATE
Onset: EARLY
Stomach Pain Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
<15.0%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
<50.0%*
Severity: MILD
Onset: DELAYED
Blood Clot In Lung Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bruises Incidence:
<40.0%*
Severity: MILD
Onset: DELAYED
Red Spotted Rash Incidence:
<21.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
<33.3%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
<6.0%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
<9.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
<8.2%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
2.2-25.0%*
Severity: MODERATE
Onset: RAPID
Low Blood Pressure Incidence:
2.2-25.0%*
Severity: MODERATE
Onset: RAPID
Elevated Hepatic Enzymes Incidence:
3.0-18.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
4.3-8.3%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
4.3-16.7%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
5.0-51.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
5.0-60.0%*
Severity: MILD
Onset: RAPID
Bladder Infection Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
5.0-13.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0-66.7%*
Severity: MILD
Onset: EARLY
Chills Incidence:
5.0-33.3%*
Severity: MILD
Onset: RAPID
Chest Pain Incidence:
5.0-15.0%*
Severity: MODERATE
Onset: EARLY
Hives Incidence:
5.0-6.0%*
Severity: MILD
Onset: RAPID
Weakness Incidence:
5.0-15.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
5.0-6.0%*
Severity: MILD
Onset: EARLY
Painful Urination Incidence:
5.0%*
Severity: MODERATE
Onset: EARLY
Eczema Vaccinatum Incidence:
5.0-7.0%*
Severity: SEVERE
Onset: DELAYED
High Bilirubin Level Incidence:
5.3-10.5%*
Severity: MODERATE
Onset: DELAYED
Throat Irritation Incidence:
5.5-7.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
6.0-9.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
6.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
6.0-33.0%*
Severity: MILD
Onset: DELAYED
Excessive Sweating Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
6.0-10.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
6.0-16.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
6.0-41.7%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
6.0-52.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
6.0-54.0%*
Severity: MILD
Onset: DELAYED
Flushing Incidence:
6.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
6.0-28.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
6.0-9.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
6.0-8.0%*
Severity: MILD
Onset: RAPID
Eye Irritation Incidence:
6.5-7.0%*
Severity: MILD
Onset: RAPID
Runny Nose Incidence:
6.5-17.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
7.0-11.0%*
Severity: MODERATE
Onset: EARLY
Migraine Incidence:
7.0%*
Severity: MODERATE
Onset: EARLY
Heartburn Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Eye Drainage Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
8.0-91.7%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
8.7-40.0%*
Severity: MILD
Onset: DELAYED
Ear Pain Incidence:
9.0-18.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
9.0%*
Severity: MODERATE
Onset: EARLY
Conjunctivitis Incidence:
9.0-13.0%*
Severity: MODERATE
Onset: DELAYED
Infusion-related Reactions Incidence:
>10.0%*
Severity: MODERATE
Onset: RAPID
Sore Throat Incidence:
10.0-41.0%*
Severity: MILD
Onset: DELAYED
Nose Bleed Incidence:
11.0-23.0%*
Severity: MILD
Onset: DELAYED
Breathing Difficulties Incidence:
14.0-29.0%*
Severity: SEVERE
Onset: RAPID
Wheezing Incidence:
14.0%*
Severity: MODERATE
Onset: RAPID
Muscle And/Or Bone Pain Incidence:
15.0-25.0%*
Severity: MILD
Onset: EARLY
Slow Heart Beat Incidence:
16.0%*
Severity: SEVERE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Baygam

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5